(RYTM) – Mergers and Acquisitions
-
M&A watch: 3 biotech companies that are most likely to be acquired - Needham
-
Rhythm Pharmaceuticals (RYTM) to Acquire Global Rights to Oral MC4R Agonist LB54640 from LG Chem Life Sciences
-
Back to RYTM Stock Lookup